ArticleThe International journal on drug policy2022
Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts.
Article in The International journal on drug policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.
- Implementation of Jail and Prison-Based Medication Treatment for Opioid Use Disorder Programs: A Narrative Synthesis.Medical care research and review : MCRR · 2025Pooled it
- The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trial.Journal of substance use and addiction treatment · 2026Trial
- A protocol for a randomized comparison of extended-release versus sublingual buprenorphine among pre-trial detainees in jail.Addiction science & clinical practice · 2025Article
- Implementation of harm reduction strategies in criminal-legal systems: a scoping review of the literature.Health & justice · 2025Review
- Patient perspectives of jail based MOUD treatment: views of individuals who have returned to the community following incarceration.Health & justice · 2025Article
- Community pharmacist-administered injectable naltrexone for individuals who were formerly incarcerated: a review of Wisconsin legislation and regulations.Substance abuse treatment, prevention, and policy · 2025Review
- The importance of contextually specific support relationships in implementing programs to link people to medication for opioid use disorder (MOUD) treatment during reentry from county jails.Health & justice · 2025Article
- The wide-angle lens of implementation science to improve health outcomes in criminal legal settings.Health & justice · 2025Review
- Barriers and facilitators to community pharmacist-provided injectable naltrexone for formerly incarcerated individuals during community reentry.Exploratory research in clinical and social pharmacy · 2025Article
- "Yeah, this is not going to work for me"-The impact of federal policy restrictions on methadone continuation upon release from jail or prison.Journal of substance use and addiction treatment · 2025Article
- Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study.Addiction science & clinical practice · 2024Article
- An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study.Psychiatric services (Washington, D.C.) · 2024Article
- Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study.Social science & medicine (1982) · 2024Article
- Provision of health care services related to substance use disorder in southern U.S. jails.Journal of substance use and addiction treatment · 2024Article
- Contextualizing medications for opioid use disorder and peer support service provision in the probation system with implementation science.BMC public health · 2024Article
- Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives.Addiction science & clinical practice · 2024Article
- Linkage facilitation services for opioid use disorder: Taxonomy of facilitation practitioners, goals, and activities.Journal of substance use and addiction treatment · 2024Review
- Access to medications for opioid use disorder for formerly incarcerated individuals during community reentry: a mini narrative review.Frontiers in public health · 2024Review
- Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts.The International journal on drug policy · 2023Article
- Contextualizing Medications for Opioid Use Disorder and Peer Support Service Provision in the Probation System with Implementation Science.Research square · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundIndividuals with opioid use disorder released to communities after incarceration experience an elevated risk for overdose death. Massachusetts is the first state to mandate county jails to deliver all FDA approved medications for opioid use disorder (MOUD). The present study considered perspectives around coordination of post-release care among jail staff engaged in MOUD programs focused on coordination of care to the community.
methodsFocus groups and semi-structured interviews were conducted with 61 jail staff involved in implementation of MOUD programs. Interview guide development, and coding and analysis of qualitative data were guided by the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework. Deductive and inductive approaches were used for coding and themes were organized using the EPIS.
resultsSalient themes in the inner context focused on the elements of reentry planning that influence coordination of post-release care including timing of initiation, staff knowledge about availability of MOUD in community settings, and internal collaborations. Findings on bridging factors highlighted the importance of interagency communication to follow pre-scheduled release dates and use of bridge scripts to minimize the gap in treatment during the transition. Use of navigators was an additional factor that influenced MOUD initiation and engagement in community settings. Outer context findings indicated partnerships with community providers and timely reinstatement of health insurance coverage as critical factors that influence coordination of post-release care.
conclusionsCoordination of MOUD post-release continuity of care requires training supporting staff in reentry planning as well as resources to enhance internal collaborations and bridging partnerships between in-jail MOUD programs and community MOUD providers. In addition, efforts to reduce systemic barriers related to unanticipated timing of release and reinstatement of health insurance coverage are needed to optimize seamless post-release care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.